RS49598B - Intermedijari i proces za dobijanje olanzapina - Google Patents

Intermedijari i proces za dobijanje olanzapina

Info

Publication number
RS49598B
RS49598B YUP-155/99A YU15599A RS49598B RS 49598 B RS49598 B RS 49598B YU 15599 A YU15599 A YU 15599A RS 49598 B RS49598 B RS 49598B
Authority
RS
Serbia
Prior art keywords
dihydrate
olanzapine
typical
ray powder
diffraction pattern
Prior art date
Application number
YUP-155/99A
Other languages
English (en)
Serbian (sr)
Inventor
Charles Arthur Bunnell
Samuel Dean Larsen
John Richard Nichols
Susan Marie Reutzel
Gregory Alan Stephenson
Original Assignee
Eli Lilly And Company,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21832120&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS49598(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eli Lilly And Company, filed Critical Eli Lilly And Company,
Publication of YU15599A publication Critical patent/YU15599A/sh
Publication of RS49598B publication Critical patent/RS49598B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
YUP-155/99A 1996-09-23 1997-09-18 Intermedijari i proces za dobijanje olanzapina RS49598B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2648796P 1996-09-23 1996-09-23

Publications (2)

Publication Number Publication Date
YU15599A YU15599A (sh) 2001-12-26
RS49598B true RS49598B (sr) 2007-06-04

Family

ID=21832120

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-155/99A RS49598B (sr) 1996-09-23 1997-09-18 Intermedijari i proces za dobijanje olanzapina

Country Status (35)

Country Link
US (1) US6020487A (en:Method)
EP (1) EP0831098B1 (en:Method)
JP (2) JP2001500877A (en:Method)
KR (1) KR100560015B1 (en:Method)
CN (1) CN1122036C (en:Method)
AR (1) AR013838A1 (en:Method)
AT (1) ATE209208T1 (en:Method)
AU (1) AU719441B2 (en:Method)
BR (1) BR9712100A (en:Method)
CA (1) CA2265712C (en:Method)
CO (1) CO4910140A1 (en:Method)
CZ (1) CZ299248B6 (en:Method)
DE (1) DE69708428T2 (en:Method)
DK (1) DK0831098T3 (en:Method)
EA (1) EA001642B1 (en:Method)
EG (1) EG23861A (en:Method)
ES (1) ES2166051T3 (en:Method)
HU (1) HU226484B1 (en:Method)
ID (1) ID27275A (en:Method)
IL (1) IL128962A (en:Method)
IN (1) IN187156B (en:Method)
MY (1) MY125565A (en:Method)
NO (1) NO323980B1 (en:Method)
NZ (1) NZ334448A (en:Method)
PE (1) PE110398A1 (en:Method)
PL (3) PL196069B1 (en:Method)
PT (1) PT831098E (en:Method)
RS (1) RS49598B (en:Method)
SI (1) SI0831098T1 (en:Method)
SV (1) SV1997000081A (en:Method)
TR (1) TR199900640T2 (en:Method)
TW (1) TW470746B (en:Method)
UA (1) UA59371C2 (en:Method)
WO (1) WO1998012199A1 (en:Method)
ZA (1) ZA978515B (en:Method)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2003108745A (ru) * 2000-08-31 2005-01-10 Др. Редди`З Лабораториз Лтд. (In) Способ получения гидратов оланзапина и превращение их в кристаллические формы оланзапина
US6740753B2 (en) 2001-01-04 2004-05-25 Geneva Pharmaceuticals, Inc. Olanzapine crystal modification
CA2464306A1 (en) * 2001-10-29 2003-05-08 Dr. Reddy's Laboratories Ltd. Olanzapine dihydrate-ii a process for its preparation and use thereof
CH695862A5 (fr) 2001-12-24 2006-09-29 Sun Pharmaceutical Ind Ltd Forme cristalline I de la methyl-4-(4-methyl-1-piperazinyl) 10H-thieno [2,3-b] [1,5] benzodiazepine.
WO2003091260A1 (en) * 2002-04-23 2003-11-06 Dr. Reddy's Laboratories Limited Novel crystalline polymorph form-vi of olanzapine and a process for preparation thereof
EP1513846B1 (en) 2002-05-31 2011-03-02 Sandoz Ag Process of preparation of olanzapine form i
SI21270A (sl) 2002-07-15 2004-02-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Kristalne oblike olanzapina in postopki za njihovo pripravo
WO2004058773A1 (en) * 2002-12-24 2004-07-15 Teva Pharmaceutical Industries Ltd. Novel crystal forms of olanzapine, methods for their preparation and method for the preparation of known olanzapine crystal forms
AU2004291043A1 (en) * 2003-11-18 2005-06-02 3M Innovative Properties Company Olanzapine containing transdermal drug delivery compositions
ATE397611T1 (de) * 2003-12-22 2008-06-15 Teva Pharma Verfahren zur herstellung von olanzapin
AR047459A1 (es) 2004-01-27 2006-01-18 Synthon Bv Sales estables de 2-metil-4-(4-metil-1-piperazinil)-10h-tieno[2,3-b][1,5]benzodiazepina (olanzapina)
US20070072845A1 (en) * 2004-02-19 2007-03-29 Davuluri Rammohan Rao Process for the preparation of olanzapine form 1 useful as antipsychotic drug
ES2289974T1 (es) * 2004-07-14 2008-02-16 Shasun Chemicals And Drugs Limited Metodo mejorado para producir la forma i de la olanzapina.
ES2253091B1 (es) 2004-07-27 2007-02-01 Inke, S.A. Solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo.
DE112005000641T5 (de) * 2004-09-06 2007-09-06 Shasun Chemicals and Drugs Ltd., Chennai Neues Verfahren zur Herstellung einer pharmazeutisch reinen polymorphen Form I von Olanzapin
EA200701065A1 (ru) * 2004-11-16 2007-12-28 Элан Фарма Интернэшнл Лтд. Инъецируемые составы, содержащие нанодисперсный оланзапин
US7834176B2 (en) 2006-01-26 2010-11-16 Sandoz Ag Polymorph E of Olanzapine and preparation of anhydrous non-solvated crystalline polymorphic Form I of 2-methyl-4(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine (Olanzapine Form I) from the polymorphic Olanzapine Form E
CA2591644A1 (en) * 2007-06-14 2008-12-14 Apotex Pharmachem Inc. Novel processes to form-i of olanzapine
EP2486913A1 (en) 2011-02-14 2012-08-15 Labtec GmbH Rapidly disintegrating oral film formulation for Olanzapin
JP6008734B2 (ja) * 2012-12-20 2016-10-19 株式会社トクヤマ オランザピンｉｉ型結晶の製造方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302716A (en) * 1986-01-16 1994-04-12 Schering Corporation Fused benzazepines
CA2002596A1 (en) * 1988-11-14 1990-05-14 Thomas M. Eckrich Hydrates of b-lactam antibiotic
GB9009229D0 (en) * 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
ATE198891T1 (de) * 1992-05-29 2001-02-15 Lilly Co Eli Thienobenzodiazepinderivate zur behandlung von störungen des zentralnervensystems
US5550231A (en) * 1993-06-15 1996-08-27 Eli Lilly And Company Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof
US5602124A (en) * 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. 5-HT2 receptor ligands
EG24221A (en) * 1995-03-24 2008-11-10 Lilly Co Eli Process for preparing olanzapine
US5631250A (en) * 1995-03-24 1997-05-20 Eli Lilly And Company Process and solvate of 2-methyl-thieno-benzodiazepine
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
US5637584A (en) * 1995-03-24 1997-06-10 Eli Lilly And Company Solvate of olanzapine
JP2001500878A (ja) * 1996-09-23 2001-01-23 イーライ・リリー・アンド・カンパニー オランザピン二水和物ｄ

Also Published As

Publication number Publication date
ZA978515B (en) 1999-03-23
EP0831098B1 (en) 2001-11-21
NZ334448A (en) 2000-08-25
WO1998012199A1 (en) 1998-03-26
AU4484197A (en) 1998-04-14
DK0831098T3 (da) 2002-05-21
IN187156B (en:Method) 2002-02-16
MY125565A (en) 2006-08-30
AU719441B2 (en) 2000-05-11
YU15599A (sh) 2001-12-26
PL194565B1 (pl) 2007-06-29
TR199900640T2 (xx) 1999-06-21
US6020487A (en) 2000-02-01
EG23861A (en) 2007-11-18
HK1009807A1 (en) 1999-06-11
ATE209208T1 (de) 2001-12-15
EA001642B1 (ru) 2001-06-25
CO4910140A1 (es) 2000-04-24
PL196068B1 (pl) 2007-12-31
SI0831098T1 (en) 2002-04-30
NO991382D0 (no) 1999-03-22
NO323980B1 (no) 2007-07-30
CN1122036C (zh) 2003-09-24
PL196069B1 (pl) 2007-12-31
PT831098E (pt) 2002-04-29
TW470746B (en) 2002-01-01
ID27275A (id) 2001-03-22
CZ299248B6 (cs) 2008-05-28
CA2265712A1 (en) 1998-03-26
KR100560015B1 (ko) 2006-03-15
HUP0000066A3 (en) 2000-11-28
HUP0000066A2 (hu) 2000-06-28
BR9712100A (pt) 1999-08-31
EA199900326A1 (ru) 1999-08-26
CZ99099A3 (cs) 1999-11-17
JP2001500877A (ja) 2001-01-23
SV1997000081A (es) 1999-01-14
ES2166051T3 (es) 2002-04-01
EP0831098A3 (en) 1998-04-29
CA2265712C (en) 2006-10-31
AR013838A1 (es) 2001-01-31
UA59371C2 (uk) 2003-09-15
IL128962A (en) 2003-01-12
CN1234802A (zh) 1999-11-10
IL128962A0 (en) 2000-02-17
JP2009242407A (ja) 2009-10-22
PL332482A1 (en) 1999-09-13
DE69708428T2 (de) 2002-07-04
PE110398A1 (es) 1999-01-14
NO991382L (no) 1999-03-22
DE69708428D1 (de) 2002-01-03
KR20000048520A (ko) 2000-07-25
EP0831098A2 (en) 1998-03-25
HU226484B1 (en) 2009-03-02

Similar Documents

Publication Publication Date Title
RS49598B (sr) Intermedijari i proces za dobijanje olanzapina
SI9620040A (sl) Postopek in kristalne oblike 2-metil-tieno-benzodiazepina
EP1373269A1 (en) Jun kinase inhibitors
RS56323B1 (sr) Proces za masovnu proizvodnju monohidrata 1-[(2-bromofenil)sulfonil]-5-metoksi-3-[(4-metil-1-piperazinil)metil]-1h-indol dimezilata
EP0733634B1 (en) Process for preparing a thieno(2,3-B)(1,5) benzodiazepine derivative
CA2493370C (en) Crystal forms of olanzapine and processes for their preparation
EP3727377B1 (en) Process for the preparation of pyrimidinyl-4-aminopyrazole compounds
NZ519926A (en) New polymorphic forms of olanzapine
HK1009807B (en) Intermediates and process for preparing olanzapine
MXPA02009232A (es) Proceso para preparar midazolam.
WO2007102167A1 (en) A process for the preparation of anhydrous polymorphic form of olanzapine
HK40039340B (en) Process for the preparation of pyrimidinyl-4-aminopyrazole compounds
HK40039340A (en) Process for the preparation of pyrimidinyl-4-aminopyrazole compounds
JP2000154189A (ja) ２−アルコキシカルボニルアミノ−１−メチル−６−フェニルイミダゾ［４，５−ｂ］ピリジン誘導体、及び該誘導体を使用した２−アミノ−１−メチル−６−フェニルイミダゾ［４，５−ｂ］ピリジンの合成法
MX2007003719A (en) Tadalafil crystal forms and processes for preparing them